Psoriasis: response to high-dose intrave
✍
V. Gurmin; R. Mediwake; M. Fernando; S. Whittaker; M.H.A. Rustin; H.L.C. Beynon
📂
Article
📅
2002
🏛
John Wiley and Sons
🌐
English
⚖ 59 KB
Treatment of recalcitrant psoriasis and psoriatic arthritis can be challenging, with treatment options limited by drug intolerance or poor efficacy. High-dose intravenous immunoglobulin (hdIVIg) has been used successfully in Kawasaki's disease and idiopathic thrombocytopenic purpura, where it has be